Bibliografia UJ CM

1/6
Iain C. Macdougall, Andrzej Wiecek, Beatriz Tucker, Magdi Yaqoob, Ashraf Mikhail, Michal Nowicki, Iain MacPhee, Michal Mysliwiec, Olgierd Smolenski, Władysław Sułowicz, Martha Mayo, Carol Francisco, Krishna R. Polu, Peter J. Schatz, Anne-Marie Duliege.
Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients.
Clinical Journal of the American Society of Nephrology
2011 : Vol. 6, nr 11, s. 2579-2586, bibliogr. 20 poz.
ISSN: 1555-9041
AZ
ORG
AIF
IF: 5.227
2/6
A.M. Duliege, R. Leong, R. Gellert, B. Rutkowski, R. Fluck, O[lgierd] Smolenski, I. MacPhee, W[ładysław] Sulowicz, A. Mikhail, A. Wiecek, M. Mysliwiec, M. Yaqoob, M. Nowicki, B. Tucker, Iain Macdougall.
Doses of hematide to increase and maintain haemoglobin in non dialysis patients are similar regardless of baseline renal function.
NDT Plus
2009 : Vol. 2 suppl. 2
World Congress of Nephrology, Milan, Italy, May 22-26 2009.
SZZ
AWZ
3/6
Iain Macdougall, Luminita Ardelean, Adrian Covic, Vilpa Silva, de, Ovidiu Golea, Michal Nowicki, Michal Mysliwiec, Wladyslaw Sulowicz, Anne-Marie Duliege, Robert Leong, Andrzej Wiecek.
Interim evaluation of long-term safety and tolerability of hematide TM during maintenance treatment of anaemia in patients with chronic kidney disease (CKD).
NDT Plus
2008 : Vol. 1 suppl. 2, s. ii362, abstr. MP381
XLV Congress of the European Renal Association (ERA-EDTA), Stockholm, Sweden, May 10-13, 2008.
SZZ
SIF
4/6
Iain C. Macdougall, B. Tucker, M. Yaqoob, A. Mikhail, M. Nowicki, I. MacPhee, M. Mysliwiec, W[ładysław] Sulowicz, A. Zamauskaite, R. Leong, J. Iwashita, A.M. Duliege, A. Wiecek.
Hematide ^TM, a synthetic peptide-based erythropoiesis stimulating agent (ESA), achieves correction of anemia and maintains hemoglobin (Hb) in patients with chronic kidney disease (CKD) not on dialysis.
Journal of the American Society of Nephrology
2006 : Vol. 17 abstract issue, s. 53A, abstr. F-FC079
Renal Week 2006: American Society of Nephrology Annual Meeting, San Diego, CA, USA, November 14-19, 2006.
SZZ
SIF
5/6
Anatole Beserab, Robert Provenzano, Iain C. Macdougall, David H. Ellison, A. Peter Maxwell, Wladyslaw Sulowicz, Frank C. Dougherty.
Dose-dependent erythropoietic responses to subcutaneous (SC) CERA (Continuous Erythropoietin Receptor Activator) in a multi-dose study of patients with Chronic Kidney Disease (CKD) not on dialysis.
W: The American Society of Nephrology (ASN) 38th Annual Meeting, November 8-13, 2005
il. : bibliogr. 3 poz.
SZZ
AWZ
6/6
Robert Provenzano, Anatole Beserab, Iain C. Macdougall, David H. Ellison, A. Peter Maxwell, Wladyslaw Sulowicz, Frank C. Dougherty.
Subcutaneous CERA (Continuous Erythropoietin Receptor Activator) maintains hemoglobin levels with administration intervals up to 3 weeks in chronic kidney disease patients not on dialysis.
W: The American Society of Nephrology (ASN) 38th Annual Meeting, November 8-13, 2005
il. : bibliogr. 3 poz.
SZZ
AWZ
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ